The In Vivo Contract Research Organization Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the In Vivo Contract Research Organization Market?
The size of the in vivo contract research organization market has been expanding significantly over the past years. The market is projected to increase from $4.82 billion in 2024 to $5.23 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 8.5%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the In Vivo Contract Research Organization Industry?
The In Vivo Contract Research Organization Global Market is projected to reach a size of $7.19 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.3%.
Download Your Free Sample of the 2025 In Vivo Contract Research Organization Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the In Vivo Contract Research Organization Market?
The key drivers in the in vivo contract research organization market are:
• The strong emphasis on personalized medicine is expected to drive the market growth.
• The ease and affordability of genomic sequencing technologies, which improve patient treatments, are contributing to this growth.
• Rising demand in the in vivo CRO market is propelled by the need for custom preclinical studies using particular animal models.
• The continuous approval of new personalized treatments by the FDA fuels the market growth.
Global Market Segmentation: Identifying Major In Vivo Contract Research Organization Industry Segments
The in vivo contract research organization market covered in this report is segmented –
1) By Type: Rodent Based, Non-Rodent Based
2) By Type Of Service: Clinical Trial Services, Preclinical Services, Post-Market Services
3) By Good Laboratory Practice Type: Good Laboratory Practice Toxicology, Non Good Laboratory Practice
4) By Applications: Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Government And Regulatory Bodies
Pre-order the 2025 In Vivo Contract Research Organization Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the In Vivo Contract Research Organization Market?
The key trends in the in vivo contract research organization market are:
• There is a growing trend towards developing innovative solutions within the in vivo contract research organization market.
• The creation of specialised programs, such as advanced therapy incubator programs, are highlighting future trends in accelerating the development of therapeutics.
• The use of program structures that provide real-world preclinical settings as a means of validating therapeutic candidates is seen as a pivotal emerging trend.
• The role of initiatives that bridge the gap between academic innovation and clinical development is becoming more prominent.
Who Are the Top Competitors & Leading Players in the In Vivo Contract Research Organization Market?
Major players in the in vivo contract research organization market are:
• Thermo Fisher Scientific Inc.
• IQVIA Inc.
• Labcorp Drug Development Inc.
• ICON plc
• Pharmaceutical Product Development LLC
• Eurofins Scientific SE
• WuXi AppTec
• Syneos Health Inc.
• Charles River Laboratories International Inc.
• Parexel International Corporation
• Evotec SE
• GemPharmatech Co Ltd.
• BIOQUAL Inc.
• Crown Bioscience Inc.
• PsychoGenics Inc.
• Janvier Labs SAS
• Taconic Bioscience Inc.
• Xentech SAS
• Pronexus Analytical AB
• Altogen Labs Inc.
• AniLocus Inc.
Regional Dominance: Which Area Leads the Global In Vivo Contract Research Organization Market?
North America was the largest region in the in vivo contract research organization market in 2024
